These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 21774911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
    Kim LHC, Hogeling M, Wargon O, Jiwane A, Adams S.
    J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
    [Abstract] [Full Text] [Related]

  • 4. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
    de Graaf M, Breur JMPJ, Raphaël MF, Vos M, Breugem CC, Pasmans SGMA.
    J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
    [Abstract] [Full Text] [Related]

  • 5. β-blockers in the treatment of periocular infantile hemangioma.
    Al-Haddad C, El Salloukh NA, El Moussawi Z.
    Curr Opin Ophthalmol; 2019 Sep; 30(5):319-325. PubMed ID: 31394556
    [Abstract] [Full Text] [Related]

  • 6. Hyperkalemia complicating propranolol treatment of an infantile hemangioma.
    Pavlakovic H, Kietz S, Lauerer P, Zutt M, Lakomek M.
    Pediatrics; 2010 Dec; 126(6):e1589-93. PubMed ID: 21115582
    [Abstract] [Full Text] [Related]

  • 7. Current concepts in the management of periocular infantile (capillary) hemangioma.
    Ni N, Guo S, Langer P.
    Curr Opin Ophthalmol; 2011 Sep; 22(5):419-25. PubMed ID: 21730838
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.
    Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA.
    Arch Dermatol; 2010 Jul; 146(7):775-8. PubMed ID: 20644039
    [Abstract] [Full Text] [Related]

  • 10. Propranolol for treatment of ulcerated infantile hemangiomas.
    Saint-Jean M, Léauté-Labrèze C, Mazereeuw-Hautier J, Bodak N, Hamel-Teillac D, Kupfer-Bessaguet I, Lacour JP, Naouri M, Vabres P, Hadj-Rabia S, Nguyen JM, Stalder JF, Barbarot S, Groupe de Recherche Clinique en Dermatologie Pédiatrique.
    J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
    [Abstract] [Full Text] [Related]

  • 11. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
    Breur JM, de Graaf M, Breugem CC, Pasmans SG.
    Pediatr Dermatol; 2011 May; 28(2):169-71. PubMed ID: 20738795
    [Abstract] [Full Text] [Related]

  • 12. Monitoring oral propranolol for infantile hemangiomata.
    Bar J, Bar-Ilan E, Cleper R, Sprecher E, Samuelov L, Mashiah J.
    Dermatol Ther; 2022 Nov; 35(11):e15870. PubMed ID: 36177767
    [Abstract] [Full Text] [Related]

  • 13. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
    Hu L, Zhou B, Huang H, Chang L, Qiu Y, Ma G, Chen H, Jin Y, Xu X, Lin X, Li W.
    J Dermatol; 2016 Oct; 43(10):1160-1166. PubMed ID: 26945921
    [Abstract] [Full Text] [Related]

  • 14. A randomized, controlled trial of oral propranolol in infantile hemangioma.
    Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ, Caceres H, Lopez Gutierrez JC, Ballona R, Friedlander SF, Powell J, Perek D, Metz B, Barbarot S, Maruani A, Szalai ZZ, Krol A, Boccara O, Foelster-Holst R, Febrer Bosch MI, Su J, Buckova H, Torrelo A, Cambazard F, Grantzow R, Wargon O, Wyrzykowski D, Roessler J, Bernabeu-Wittel J, Valencia AM, Przewratil P, Glick S, Pope E, Birchall N, Benjamin L, Mancini AJ, Vabres P, Souteyrand P, Frieden IJ, Berul CI, Mehta CR, Prey S, Boralevi F, Morgan CC, Heritier S, Delarue A, Voisard JJ.
    N Engl J Med; 2015 Feb 19; 372(8):735-46. PubMed ID: 25693013
    [Abstract] [Full Text] [Related]

  • 15. Treatment of infantile hemangiomas with beta-blockers: a review.
    Shah S, Frieden IJ.
    Skin Therapy Lett; 2013 Feb 19; 18(6):5-7. PubMed ID: 24305730
    [Abstract] [Full Text] [Related]

  • 16. Twenty-four-hour hospitalization for patients initiating systemic propranolol therapy for infantile hemangiomas--is it indicated?
    Liu LS, Sokoloff D, Antaya RJ.
    Pediatr Dermatol; 2013 Feb 19; 30(5):554-60. PubMed ID: 23829941
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy].
    Michel JL, Patural H.
    Arch Pediatr; 2009 Dec 19; 16(12):1565-8. PubMed ID: 19892536
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety assessment during initiation and maintenance of propranolol therapy for infantile hemangiomas.
    Babiak-Choroszczak L, Giżewska-Kacprzak K, Dawid G, Gawrych E, Bagłaj M.
    Adv Clin Exp Med; 2019 Mar 19; 28(3):375-384. PubMed ID: 30659785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.